PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 124 filers reported holding PUMA BIOTECHNOLOGY INC in Q4 2020. The put-call ratio across all filers is 0.95 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $192,996 | -4.4% | 62,458 | +30.8% | 0.00% | 0.0% |
| Q4 2022 | $201,978 | +320.8% | 47,749 | +136.6% | 0.00% | – |
| Q3 2022 | $48,000 | -12.7% | 20,181 | +5.3% | 0.00% | – |
| Q2 2022 | $55,000 | -76.4% | 19,166 | -76.3% | 0.00% | -100.0% |
| Q1 2022 | $233,000 | +37.1% | 80,801 | +44.5% | 0.00% | 0.0% |
| Q4 2021 | $170,000 | +9.0% | 55,901 | +151.8% | 0.00% | 0.0% |
| Q3 2021 | $156,000 | -54.7% | 22,200 | -35.0% | 0.00% | 0.0% |
| Q3 2020 | $344,000 | -18.3% | 34,134 | -15.4% | 0.00% | -50.0% |
| Q2 2020 | $421,000 | +46.2% | 40,334 | +18.2% | 0.00% | 0.0% |
| Q1 2020 | $288,000 | -34.8% | 34,134 | -32.5% | 0.00% | +100.0% |
| Q4 2019 | $442,000 | +22.8% | 50,567 | +543.3% | 0.00% | 0.0% |
| Q3 2018 | $360,000 | – | 7,860 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Athyrium Capital Management, LP | 1,792,114 | $5,108,000 | 2.15% |
| Camber Capital Management LP | 4,235,000 | $12,070,000 | 0.52% |
| Kynam Capital Management, LP | 579,915 | $1,653,000 | 0.42% |
| GLOBEFLEX CAPITAL L P | 419,322 | $1,195,000 | 0.29% |
| Eversept Partners, LP | 1,435,077 | $4,089,969 | 0.29% |
| ARMISTICE CAPITAL, LLC | 1,500,000 | $4,275,000 | 0.08% |
| RICE HALL JAMES & ASSOCIATES, LLC | 506,066 | $1,442,000 | 0.07% |
| XTX Topco Ltd | 36,130 | $103,000 | 0.04% |
| State of Wyoming | 20,732 | $59,000 | 0.04% |
| Patriot Financial Group Insurance Agency, LLC | 55,500 | $158,000 | 0.03% |